132 related articles for article (PubMed ID: 36267733)
1. Current usage and challenges of master protocols-based on survey results by ASA BIOP oncology methodology working group master protocol sub-team.
Li X; Lu C; Broglio K; Bycott P; Chen J; Jiang Q; Lin J; Ye J; Yin J
Ann Transl Med; 2022 Sep; 10(18):1036. PubMed ID: 36267733
[TBL] [Abstract][Full Text] [Related]
2. Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team.
Dong Y; Paux G; Broglio K; Cooner F; Gao G; He W; Gao L; Xue X; He P
Ther Innov Regul Sci; 2024 Jun; ():. PubMed ID: 38909174
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
[TBL] [Abstract][Full Text] [Related]
4. Aiding the Adoption of Master Protocols by Optimizing Patient Engagement.
Huml RA; Collyar D; Antonijevic Z; Beckman RA; Quek RGW; Ye J
Ther Innov Regul Sci; 2023 Nov; 57(6):1136-1147. PubMed ID: 37615880
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.
Meyer EL; Mesenbrink P; Dunger-Baldauf C; Fülle HJ; Glimm E; Li Y; Posch M; König F
Clin Ther; 2020 Jul; 42(7):1330-1360. PubMed ID: 32622783
[TBL] [Abstract][Full Text] [Related]
6. Master protocol trials in oncology: Review and new trial designs.
Hirakawa A; Asano J; Sato H; Teramukai S
Contemp Clin Trials Commun; 2018 Dec; 12():1-8. PubMed ID: 30182068
[TBL] [Abstract][Full Text] [Related]
7. Reporting of master protocols towards a standardized approach: A systematic review.
Siden EG; Park JJ; Zoratti MJ; Dron L; Harari O; Thorlund K; Mills EJ
Contemp Clin Trials Commun; 2019 Sep; 15():100406. PubMed ID: 31334382
[TBL] [Abstract][Full Text] [Related]
8. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
[TBL] [Abstract][Full Text] [Related]
9. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
10. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics.
Li Y; Nelson R; Izem R; Broglio K; Mundayat R; Gamalo M; Wen Y; Pan H; Sun H; Ye J
Ther Innov Regul Sci; 2024 Jul; 58(4):634-644. PubMed ID: 38653950
[TBL] [Abstract][Full Text] [Related]
11. Design and analysis of umbrella trials: Where do we stand?
Ouma LO; Wason JMS; Zheng H; Wilson N; Grayling M
Front Med (Lausanne); 2022; 9():1037439. PubMed ID: 36313987
[TBL] [Abstract][Full Text] [Related]
12. Mobilizing the clinical trial ecosystem to drive adoption of master protocols.
Bronson A; Chase MK; Fisher K; Millar D; Perlmutter J; Richardson N
Clin Trials; 2022 Dec; 19(6):690-696. PubMed ID: 36086812
[TBL] [Abstract][Full Text] [Related]
13. Challenges with Novel Clinical Trial Designs: Master Protocols.
Cecchini M; Rubin EH; Blumenthal GM; Ayalew K; Burris HA; Russell-Einhorn M; Dillon H; Lyerly HK; Reaman GH; Boerner S; LoRusso PM
Clin Cancer Res; 2019 Apr; 25(7):2049-2057. PubMed ID: 30696689
[TBL] [Abstract][Full Text] [Related]
14. Community engagement and involvement in Ghana: conversations with community stakeholders to inform surgical research.
Kroese K; Ofori BA; Abdulai DR; Monahan M; Prah A; Tabiri S
Res Involv Engagem; 2021 Jul; 7(1):50. PubMed ID: 34225824
[TBL] [Abstract][Full Text] [Related]
15. The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review.
Gilbert A; Samuel R; Cagney D; Sebag-Montefiore D; Brown J; Brown SR
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38720568
[TBL] [Abstract][Full Text] [Related]
16. Considerations for master protocols using external controls.
Chen J; Li XN; Lu CC; Yuan S; Yung G; Ye J; Tian H; Lin J
J Biopharm Stat; 2024 Feb; ():1-23. PubMed ID: 38363805
[TBL] [Abstract][Full Text] [Related]
17. Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.
Peeva E; Banerjee A; Banfield C; Soma K; Christensen J; Menon S; Vincent MS; Dolsten M
Drug Discov Today; 2024 May; 29(5):103948. PubMed ID: 38460567
[TBL] [Abstract][Full Text] [Related]
18. Master protocols: New directions in drug discovery.
Bogin V
Contemp Clin Trials Commun; 2020 Jun; 18():100568. PubMed ID: 32395664
[TBL] [Abstract][Full Text] [Related]
19. Master protocols in clinical trials: a universal Swiss Army knife?
Sudhop T; Brun NC; Riedel C; Rosso A; Broich K; Senderovitz T
Lancet Oncol; 2019 Jun; 20(6):e336-e342. PubMed ID: 31162107
[TBL] [Abstract][Full Text] [Related]
20. Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.
Collignon O; Gartner C; Haidich AB; James Hemmings R; Hofner B; Pétavy F; Posch M; Rantell K; Roes K; Schiel A
Clin Pharmacol Ther; 2020 May; 107(5):1059-1067. PubMed ID: 32017052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
